ロード中...
Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
BACKGROUND: Rebamipide with mucin secretagogue activity was recently approved for the treatment of dry eye. The efficacy and safety in the treatment of rebamipide were shown in two pivotal clinical trials. It was the aim of this study to evaluate the effect of 2 % rebamipide ophthalmic suspension in...
保存先:
| 出版年: | BMC Ophthalmol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4456696/ https://ncbi.nlm.nih.gov/pubmed/26048396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0040-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|